The Albumin Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the albumin market has seen robust growth lately. The market size was $6.57 billion in 2024 and it is predicted to increase to $7.18 billion in 2025, demonstrating a Compound Annual Growth Rate (CAGR) of 9.3%.
The Albumin market is forecasted to grow to $10.16 billion by 2029, at a compound annual growth rate (CAGR) of 9.1%.
Download Your Free Sample of the 2025 Albumin Market Report and Uncover Key Trends Now!The drivers in the albumin market are:
• Rising prevalence of liver diseases
• Expanding applications in regenerative medicine and diagnostics
• Growth due to aging population
• Growing awareness and understanding of the importance of maintaining optimal protein levels.
The albumin market covered in this report is segmented –
1) By Type: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin
2) By Application: Therapeutics, Drug Formulation And Vaccines, Component Of Media, Other Applications
3) By Sales Channel: Business-To-Consumer (B2C), Business-To-Business (B2B)
4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Research Institutes
The trends in the albumin market are:
• There is a trend of expanding therapeutic applications of albumin.
• The use of albumin in drug delivery systems is on the rise.
• Increased demand for albumin in cell culture media is becoming a notable trend.
• Personalized medicine is driving advancements in the albumin market, particularly in recombinant technology.
The major players in the albumin market are:
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Inc.
North America was the largest region in the albumin market in 2024